Sources | Names Used |
---|---|
CCLE, GRAY | PF-2341066 |
GDSC1000, FIMM | Crizotinib |
gCSI, CTRPv2 | crizotinib |
PharmacoGx | Crizotinib |
Database | Identifier |
---|---|
Smiles: | CC(C1=C(C=C(C=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N |
Inchikey: | SCJHEFQWKWHQTO-GFCCVEGCSA-N |
Pubchem: | 54613769 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GZMH | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | IER5L | GDSC1000 | pan-cancer | AAC | 0.31 | 2e-06 |
mRNA | CRYBG3 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-06 |
mRNA | UVRAG | GDSC1000 | pan-cancer | AAC | -0.29 | 2e-06 |
mRNA | TNS3 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-06 |
mRNA | NKG7 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | THPO | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-06 |
mRNA | USP32 | CCLE | pan-cancer | AAC | 0.21 | 3e-06 |
mRNA | SLC25A37 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | ARFGEF2 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |